V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013802 | 220019830 | null | 65.2 | Curative (C) | 2014-04-26 | 2015-06-28 | Dasatinib | N | null | 220031258 | DASATINIB |
| 220013803 | 220008225 | 1.87 | null | Curative (C) | 2016-07-27 | 2016-10-23 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | 220031271 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013804 | 220014484 | 1.8 | null | Palliative (P) | 2013-11-19 | 2013-11-19 | Dasatinib | 02 | N | 220031273 | DASATINIB |
| 220013805 | 220014484 | null | 74 | Disease modification (D) | 2014-09-29 | 2014-11-26 | AML18 PILOT TRIAL | 01 | N | 220031273 | PILOT TRIAL |
| 220013807 | 220008230 | 1.62 | 0 | Neo-adjuvant (N) | 2014-09-07 | 2014-09-07 | Dasatinib | N | N | 220031279 | DASATINIB |
| 220013808 | 220008231 | 1.6 | null | Palliative (P) | 2014-01-09 | 2014-01-12 | Dasatinib | 2 | N | 220031285 | DASATINIB |
| 220013809 | 220008231 | 1.6 | null | Curative (C) | 2015-03-20 | 2015-04-26 | Rituximab | N | N | 220031285 | RITUXIMAB |
| 220013810 | 220008233 | 1.61 | 58.5 | Curative (C) | 2016-05-30 | 2016-05-30 | AML 18 TRIAL | Y | N | 220031294 | AML18 TRIAL |
| 220013811 | 220008234 | null | 79.2 | Curative (C) | 2017-04-21 | 2017-05-07 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031298 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013812 | 220008235 | 1.31 | 68.5 | Disease modification (D) | 2015-08-25 | 2015-08-25 | Rituximab | N | N | 220031299 | RITUXIMAB |
| 220013814 | 220008239 | 1.65 | 76 | T | 2014-06-07 | 2014-06-11 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220031302 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013815 | 220022102 | 1.7 | 78.8 | Curative (C) | 2014-05-05 | 2014-05-08 | Rituximab | null | N | 220031303 | RITUXIMAB |
| 220013816 | 220022102 | 1.59 | 74.4 | Curative (C) | 2017-08-09 | 2017-08-17 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220031303 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013817 | 220008242 | null | 65.4 | Disease modification (D) | 2014-08-02 | 2014-09-03 | AML18 PILOT TRIAL | N | null | 220031309 | PILOT TRIAL |
| 220013818 | 220008243 | 1.75 | 65.7 | Disease modification (D) | 2017-09-24 | 2017-12-12 | Rituximab | N | null | 220031309 | RITUXIMAB |
| 220013819 | 220008243 | 1.73 | 0 | Palliative (P) | 2016-08-17 | 2016-08-20 | Dasatinib | 01 | N | 220031309 | DASATINIB |
| 220013820 | 220008243 | 1.69 | 73.4 | Curative (C) | 2017-05-12 | 2017-08-31 | AML18 PILOT TRIAL | Y | Y | 220031309 | PILOT TRIAL |
| 220013821 | 220020938 | 1.62 | 62 | Curative (C) | 2017-04-04 | 2017-05-29 | AML18 PILOT TRIAL | Y | N | 220031331 | PILOT TRIAL |
| 220013822 | 220008244 | 1.67 | 88.7 | Curative (C) | 2015-09-25 | 2015-11-02 | AML 18 TRIAL | Y | N | 220031337 | AML18 TRIAL |
| 220013823 | 220008245 | null | 75 | Curative (C) | 2017-12-16 | 2017-12-24 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220031338 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013824 | 220008246 | 1.58 | 44.7 | null | 2017-01-12 | 2017-01-19 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | null | 220031339 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013825 | 220008247 | null | 111.2 | Disease modification (D) | 2014-01-10 | 2014-06-06 | AML 18 TRIAL | 1 | N | 220031344 | AML18 TRIAL |
| 220013826 | 220017916 | 1.6 | null | Curative (C) | 2015-12-30 | 2016-01-03 | Dasatinib | N | null | 220031347 | DASATINIB |
| 220013827 | 220017916 | 0 | 53.7 | Curative (C) | 2014-01-09 | 2014-01-09 | Dasatinib | 02 | N | 220031347 | DASATINIB |
| 220013828 | 220014493 | 1.69 | 92 | Curative (C) | 2016-04-19 | 2016-04-23 | Rituximab | N | N | 220031352 | RITUXIMAB |
| 220013829 | 220008249 | 1.7 | 84 | Curative (C) | 2014-02-14 | 2014-02-21 | Alemtuz+Fludara+Melphalan RIC MUD | Y | N | 220031359 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013830 | 220008249 | null | null | Curative (C) | 2017-02-20 | 2017-03-03 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220031359 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013831 | 220008249 | 1.61 | 81 | Curative (C) | 2012-02-17 | 2013-03-31 | Dasatinib | 99 | N | 220031359 | DASATINIB |
| 220013832 | 220008249 | null | 110 | Curative (C) | null | 2016-03-25 | AML 18 TRIAL | Y | null | 220031359 | AML18 TRIAL |
| 220013833 | 220008250 | null | 96 | Curative (C) | 2014-04-13 | 2015-08-23 | Dasatinib | 99 | N | 220031392 | DASATINIB |
| 220013834 | 220008256 | 1.81 | 73.4 | null | 2016-08-02 | 2016-08-03 | AML18 PILOT TRIAL | N | null | 220031393 | PILOT TRIAL |
| 220013835 | 220008257 | 1.84 | 87 | Curative (C) | 2013-06-05 | 2013-06-10 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220031395 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013836 | 220008258 | 1.83 | 80.85 | Disease modification (D) | 2015-05-19 | 2015-12-16 | Rituximab | N | N | 220031398 | RITUXIMAB |
| 220013837 | 220008258 | 1.83 | 96 | Curative (C) | 2016-03-06 | 2016-05-27 | AML18 PILOT TRIAL | 1 | N | 220031398 | PILOT TRIAL |
| 220013839 | 220008262 | 1.64 | 58 | Disease modification (D) | 2014-07-09 | 2014-07-30 | AML 18 TRIAL | 1 | N | 220031403 | AML18 TRIAL |
| 220013840 | 220008262 | 1.72 | 83.3 | Curative (C) | 2017-01-27 | 2017-04-21 | Dasatinib | N | N | 220031403 | DASATINIB |
| 220013841 | 220014501 | 1.72 | 67.2 | Curative (C) | 2015-09-23 | 2015-11-04 | AML18 PILOT TRIAL | null | N | 220031416 | PILOT TRIAL |
| 220013842 | 220017922 | 1.69 | null | Curative (C) | 2017-12-27 | 2018-01-10 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220031416 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013843 | 220008269 | 1.74 | null | Palliative (P) | 2016-11-11 | 2016-11-12 | Dasatinib | 2 | N | 220031434 | DASATINIB |
| 220013844 | 220008269 | 1.72 | null | Palliative (P) | 2014-04-01 | 2014-04-01 | Dasatinib | N | N | 220031434 | DASATINIB |
| 220013845 | 220008273 | 1.8 | 0 | Disease modification (D) | 2017-07-17 | 2017-07-21 | Rituximab | N | N | 220031440 | RITUXIMAB |
| 220013846 | 220014503 | 1.79 | 82.6 | Curative (C) | 2015-08-21 | 2015-08-21 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220031441 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013847 | 220014504 | 1.78 | 96 | Curative (C) | 2013-12-30 | 2013-12-30 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | 220031449 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013848 | 220008275 | 1.84 | 0 | Palliative (P) | null | 2014-04-30 | Dasatinib | 02 | N | 220031455 | DASATINIB |
| 220013849 | 220008278 | null | 0 | Curative (C) | 2015-02-18 | 2015-02-21 | Dasatinib | N | null | 220031465 | DASATINIB |
| 220013850 | 220008279 | 1.81 | 138 | Curative (C) | 2014-06-25 | 2014-10-30 | Dasatinib | N | null | 220031468 | DASATINIB |
| 220013856 | 220008281 | 1.63 | 0 | Palliative (P) | 2016-09-14 | 2016-09-14 | Dasatinib | 2 | N | 220031479 | DASATINIB |
| 220013857 | 220008283 | 1.54 | 70 | Curative (C) | 2014-08-12 | 2014-08-14 | Rituximab (Maintenance) | N | N | 220031482 | RITUXIMAB |
| 220013858 | 220008285 | 1.56 | 80.6 | Disease modification (D) | 2013-11-13 | 2013-11-21 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | N | 220031491 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013859 | 220014508 | 1.75 | 80.9 | Curative (C) | 2016-12-29 | 2017-04-18 | AML18 PILOT TRIAL | N | N | 220031493 | PILOT TRIAL |